Behind the markets
Behind the markets

Daily Trades

December 2023 Issue: Altimmune, Inc. (SYM: ALT)

For our December issue, I’m adding a stock to our weight-loss trade: Altimmune (SYM: ALT) here at $3.75.
Learn More

November 2023 Issue: Esperion Therapeutics (SYM: ESPR)

When I see that the stock is selling for just $1.19 per share - and billionaire investors Steve Cohen and Jim Simons own 3.5 million shares, count me interested.
Learn More

Our #1 Micro-Cap Biotech Stock for April – Esperion Therapeutics (ESPR)

Pharmaceutical company Esperion Therapeutics (SYM: ESPR) develops and commercializes medicines for the treatment of patients with elevated lowdensity lipoprotein cholesterol, or LDL – the “bad” cholesterol, which makes up a good deal of your body’s total cholesterol.
Learn More

March 2023 Issue: Schrodinger (SYM: SDGR)

A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it. 
Learn More

March 2022 Issue – Esperion Therapeutics

At around $5 per share, I think Esperion Therapeutics (SYM: ESPR), will go down as one of the best biotech buys you’ve ever made.
Learn More

January 2022 Issue: FDA Approvable Letter Calendar & Updates

Learn More

September 2020 Issue: Combating Cardiovascular Disease

Learn More

Combating Cardiovascular Disease

Learn More

deal of the month

best growth stocks

Alliance

Bundle package – lifetime subscriptions for all products

Get Deal

Categories

Behind the Markets

796 subscribers

Behind the Markets: independent research for independent investors.

Behind the Markets
In this video, we'll explore the recent turbulence affecting small-cap stocks, particularly in the biotech sector. Dylan will share essential strategies to maintain your composure amidst market chaos. Drawing from his early experiences on Wall Street and advice from mentors, Dylan explains why it's crucial not to "pee on the rug at the first sound of thunder." You'll learn about the importance of investing in solid businesses and not panicking at the first sign of trouble. If you're feeling uncertain about your investments, this video provides practical advice and encouragement. Please hit like, subscribe, and share if you find these insights helpful. Remember to stay calm and resilient, because steady wins the race! ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkVoQ09KWVBnT3lB

Handling Market Dips: A Little Advice from a Wall Street Insider

In this video, we dive deep into the current geopolitical tensions involving the United States, Israel, and Iran. Our video dissects the possible repercussions of an escalated conflict in the Middle East and why it might be a catastrophic mistake for the U.S. to engage in a war that doesn't align with national security priorities. We explore the historical context of the shadow war between Israel and Iran, and the implications of Israel's recent actions that indirectly involved Iranian territory. This includes the strike on an Iranian consulate, a move that escalated tensions but was met with a measured response from Iran, indicating a possible avoidance of further escalation. Additionally, the video sheds light on the broader implications for U.S. foreign policy, emphasizing the importance of focusing on domestic priorities and strategic international investments, like supporting Ukraine and monitoring developments in Taiwan due to its significance in semiconductor production. Join us as we unravel the complexities of these interactions, the potential mistakes in escalating conflicts, and the strategic choices the U.S. might consider to maintain global stability while securing its interests. Your thoughts and opinions are invaluable—share them in the comments below and let's discuss what the future should hold for U.S. involvement in Middle East affairs. ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkxROHJOTHBIX2t3

Israel vs. Iran: The Mistake That Could Drag the U.S. into War

In today’s video, we delve deep into the often overlooked geopolitical risks associated with our global dependency on artificial intelligence (AI) technologies. While AI continues to shape the future in extraordinary ways, there's a critical factor that might disrupt this progress: the semiconductor supply chain. Most of the world's advanced semiconductors, crucial for everything from mobile phones to AI systems, are manufactured in Taiwan by Taiwan Semiconductor Manufacturing Company (TSMC). However, with rising tensions in the region and China's increasing assertiveness towards Taiwan, the stability of this supply chain is under significant threat. In the past month alone, major companies like Samsung, TSMC, and Intel have received substantial funding from the U.S. government, aimed at boosting semiconductor production within the United States. This strategic move highlights a growing awareness of the risks posed by potential conflicts in Taiwan—a scenario that could have profound impacts on global technology supply chains. Join us as we analyze these complex dynamics, including the strategic moves by global and national powers to secure semiconductor production, and discuss the potential implications on AI development and broader technological advancements. We'll also offer insights into the actions companies and governments are taking to mitigate these risks. Don't forget to like, subscribe, and click the bell icon to stay updated on our latest content, where we continue to uncover the critical intersections between technology and geopolitics. Share your thoughts in the comments below: How do you think these developments will affect the future of technology and global stability? ✅ SUBSCRIBE TO THE CHANNEL 👇🏼👇🏼 https://www.youtube.com/channel/UCczJ4YRRQLl6KrH06iapaRw?sub_confirmation=1 ✅ VISIT OUR WEBSITE 👇🏼👇🏼 https://behindthemarkets.com/
YouTube Video VVVjeko0WVJSUUxsNktySDA2aWFwYVJ3LkxzZ0ZxaUhtYVpJ

The Looming Threat to Nvidia and AI

Load More... Subscribe

Recent posts

Chart of Day: Marathon Digital (MARA) – 4/24

3 Top Ways to Trade Flying Cars Today – 4/24

Top Ways to Trade the Growing Cyber Threat

Chart of Day: Barrick Gold (GOLD) – 4/23

Tags

Connect with Us

Icon-facebook Icon-btmshare_tw

December 2023 Issue: Altimmune, Inc. (SYM: ALT)

For our December issue, I’m adding a stock to our weight-loss trade: Altimmune (SYM: ALT) here at $3.75.
Learn More

November 2023 Issue: Esperion Therapeutics (SYM: ESPR)

When I see that the stock is selling for just $1.19 per share - and billionaire investors Steve Cohen and Jim Simons own 3.5 million shares, count me interested.
Learn More

Our #1 Micro-Cap Biotech Stock for April – Esperion Therapeutics (ESPR)

Pharmaceutical company Esperion Therapeutics (SYM: ESPR) develops and commercializes medicines for the treatment of patients with elevated lowdensity lipoprotein cholesterol, or LDL – the “bad” cholesterol, which makes up a good deal of your body’s total cholesterol.
Learn More

March 2023 Issue: Schrodinger (SYM: SDGR)

A.I. has started to revolutionize drug discovery. You see, right now there are a about 6,000 genetic diseases known to mankind – Liver Disease…Diabetes…Skin Cancer...Heart Disease… You name it. 
Learn More

March 2022 Issue – Esperion Therapeutics

At around $5 per share, I think Esperion Therapeutics (SYM: ESPR), will go down as one of the best biotech buys you’ve ever made.
Learn More

January 2022 Issue: FDA Approvable Letter Calendar & Updates

Learn More

September 2020 Issue: Combating Cardiovascular Disease

Learn More

Combating Cardiovascular Disease

Learn More

Get FREE Daily Stock Tips

Join and receive market insider stock picks, trade alerts and unique investing insights
This field is for validation purposes and should be left unchanged.
By clicking the "Subscribe" button you are accepting our Terms of Use and Privacy Policy.
Behind the markets

Company

Explore

CUSTOMER SERVICE

  • We’re here to help.
    Contact Us:
    Mon – Fri | 10 AM – 7 PM EST
  • 1-800-851-1965

© 2024 Behind the Markets, LLC. All rights reserved.

Join Waitlist

We’re sorry, but due to the popularity of our services, we have reached our max number of subscribers and are not currently accepting more. If spots become available, we will be sure to contact you. Please join the waitlist below.
Thank You!

"*" indicates required fields

Name*
This field is for validation purposes and should be left unchanged.